Why We Should Care About Changes In The Pharmaceutical Industry
Category: FIFTY
The pharmaceutical sector is still struggling to find an operating model that will work in the 21st century. The shocking news of GlaxoSmithKline's sale of its cancer-drug business to Novartis -- and the many recent huge deals like it -- are the most recent evidence.
By Michael Hodin, ContributorCEO, Global Coalition on Aging, 2014-05-13